Cancer Research

Researchers Say PGE2 Is Behind The Puzzling Medical Condition 'Finger Clubbing'

Researchers at the University of Leeds say they have solved a medical condition that puzzled Hippocrates more than 2,000 years ago. The phenomenon of "finger clubbing", a deformity of the fingers and fingernails, has been known for thousands of y ...

Article - News Staff - May 30 2008 - 9:29am

MammaPrint(R) Breast Cancer Test Provides Valuable Insight For Personalized Treatment Decisions

CHICAGO, May 30 /PRNewswire/--- Results presented at major U.S. cancer conference Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, announced today that data from two studies involving its MammaPrint(R) breast cancer progn ...

Article - Anna Ohlden - May 30 2008 - 11:30am

New Report Shows That Despite Poor Survival Rates Lung Cancer Is Not Prioritized In Europe

STOCKHOLM, May 30 /PRNewswire/--- Report Benchmarks the Current State of Lung Cancer Care Across Europe The fragmented organization and management of lung cancer diagnosis and care in many European countries are exacerbating already poor survival rates am ...

Article - Anna Ohlden - May 30 2008 - 12:32pm

Patients With Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)

BASEL, Switzerland, May 31 /PRNewswire/--- Results Confirm Previously Demonstrated Survival Advantages of Tarceva in This Difficult-to-Treat Disease- ABSTRACT No: 4507 Adding Avastin (bevacizumab) to a combination of Tarceva (erlotinib) and chemotherapy s ...

Article - Anna Ohlden - May 31 2008 - 8:30am

Erbitux Significantly Prolongs Survival In 1st-Line Treatment Of Non-Small Cell Lung Cancer

CHICAGO and DARMSTADT, Germany, May 31 /PRNewswire/--- New Data Provides the Basis for the Future Role of Erbitux (cetuximab) as a Standard in Combination With Platinum-Based Chemotherapy in the 1st-Line Treatment of Patients With Non-Small Cell Lung Canc ...

Article - Anna Ohlden - May 31 2008 - 9:32am

Major Independent Trial Demonstrates Significant Anticancer Benefit Of Zometa(R) In Premenopausal Women With Early-Stage Breast

FRIMLEY, England, May 31 /PRNewswire/--- Zometa When Added to Hormone Therapy, Following Surgery, Significantly Reduced the Risk of Cancer Returning or Death by 36% Beyond Clinical Benefits Achieved With Hormone Therapy Alone (1)- Findings may Allow Clini ...

Article - Anna Ohlden - May 31 2008 - 9:32am

MicroRNAs And The Genetics Of Schizophrenia

Researchers at Columbia University Medical Center have illuminated a window into how abnormalities in microRNAs, a family of molecules that regulate expression of numerous genes, may contribute to the behavioral and neuronal deficits associated with schizo ...

Article - News Staff - May 31 2008 - 10:22pm

Soil Bacteria For Antibiotics Gets A Second Look

In 1928 Alexander Fleming discovered penicillin, which was subsequently developed into a medicine by Florey and Chain in the 1940s. The antibiotic was hailed as a 'miracle cure' and a golden age of drug discovery followed. However, frequent redis ...

Article - News Staff - Jun 1 2008 - 8:04pm

Wyeth Initiates INTORACT-- A New Clinical Trial To Examine TORISEL Plus Avastin For First-Line Treatment Of Advanced Kidney Can

COLLEGEVILLE, Pennsylvania, June 2 /PRNewswire/-- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the INTORACT (Investigation of TORISEL And bevacizumab Combination Therapy) study, a worldwide randomized, open-lab ...

Article - Anna Ohlden - Jun 2 2008 - 12:30am

Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results At ASCO Annual Meeting

CALGARY, Canada, June 2 /PRNewswire/-- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented yesterday at the American ...

Article - Anna Ohlden - Jun 2 2008 - 1:33am